John Iskander
- Health top 2%
- Vaccine Coverage and Hesitancy 10
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions 4
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 4
- Microbiology top 5%
- Bacterial Infections and Vaccines 5
- Epidemiology top 10%
- Influenza Virus Research Studies 8
-
- Bacillus and Francisella bacterial research 3
-
- Pharmaceutical studies and practices 3
-
- Diphtheria, Corynebacterium, and Tetanus 2
- Co-authors
- Robert BallM. Miles BraunFrederick VarricchioRobert PlessRobert T. ChenFrank DeStefanoPenina HaberEmily Jane Woo
- Cited by
- HealthToxicologyInfectious Diseases
- Journals
- Vaccine (6 papers)PEDIATRICS (4 papers)MMWR Morbidity and Mortality Weekly Report (3 papers)
- Partner nations
- United States
In The Last Decade
John Iskander
24 papers receiving 897 citations
Peers
Comparison fields: 5 of 88
- Health 275
- Toxicology 89
- Infectious Diseases 333
- Microbiology 95
- Epidemiology 372
Countries citing papers authored by John Iskander
This map shows the geographic impact of John Iskander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Iskander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Iskander more than expected).
Fields of papers citing papers by John Iskander
This network shows the impact of papers produced by John Iskander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Iskander. The network helps show where John Iskander may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Iskander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 17 | |
| 2 | 2011 | 5 | |
| 3 | 2010 | 22 | |
| 4 | 2010 | 21 | |
| 5 | 2009 | 24 | |
| 6 | 2009 | 33 | |
| 7 | 2009 | 46 | |
| 8 | 2009 | 23 | |
| 9 | 2009 | 29 | |
| 10 | 2008 | 18 | |
| 11 | 2008 | 5 | |
| 12 | 2007 | 1 | |
| 13 | 2007 | 36 | |
| 14 | 2006 | 34 | |
| 15 | 2005 | 7 | |
| 16 | 2005 | 59 | |
| 17 | Monitoring vaccine safety during an influenza pandemic. | 2005 | 15 |
| 18 | 2005 | 56 | |
| 19 | 2004 | 9 | |
| 20 | 2004 | 295 |
About John Iskander
John Iskander is a scholar working on Health, Toxicology, Microbiology, Endocrinology and Epidemiology, having authored 24 papers that have together received 944 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (10 papers), Influenza Virus Research Studies (8 papers), Bacterial Infections and Vaccines (5 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Bacillus and Francisella bacterial research (3 papers), Pharmaceutical studies and practices (3 papers) and Diphtheria, Corynebacterium, and Tetanus (2 papers). The work is most often cited by research in Health (275 citations), Toxicology (89 citations), Infectious Diseases (333 citations), Microbiology (95 citations) and Epidemiology (372 citations). John Iskander has collaborated with scholars based in United States. Frequent co-authors include Robert Ball, M. Miles Braun, Frederick Varricchio, Robert Pless, Robert T. Chen, Frank DeStefano, Penina Haber, Emily Jane Woo, Héctor S. Izurieta and Vitali Pool. Their work appears in journals such as Vaccine, PEDIATRICS, MMWR Morbidity and Mortality Weekly Report, Drug Safety and The Pediatric Infectious Disease Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.